Shandong, China

Huanlan Zheng

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huanlan Zheng. Retrieved from https://idiyas.com/inventor/huanlan-zheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huanlan Zheng: Innovator in Pharmaceutical Composition

Introduction

Huanlan Zheng is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.

Latest Patents

Huanlan Zheng holds a patent for a composition comprising aflibercept and a variant thereof. This patent describes a composition where the variant is a truncation variant with a truncated VEGF binding portion of aflibercept. The content of the truncation variant is less than or equal to about 20% by mass percentage. Additionally, the patent includes a pharmaceutical formulation comprising this composition. It also outlines a method for detecting the variant and its use in quality inspection or quality control of an aflibercept-containing product. He has 1 patent to his name.

Career Highlights

Huanlan Zheng is associated with Qilu Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating effective therapeutic solutions that address various medical needs.

Collaborations

Huanlan Zheng has collaborated with notable colleagues, including Yue Yu and Guijiang Wang, to further enhance the impact of his research and innovations.

Conclusion

Huanlan Zheng's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the medical field. His work continues to influence the development of effective treatments and quality control measures in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…